Infliximab

clinical grade

BATCH NUMBER: EC1216

232,00 

Therapeutic Infliximab from the biosimilar Flixabi® commercial drug
Bulk deal
Quantity Discount
5 - 9 5%
10 - 14 10%
15 - 24 15%
25 + 25%

.

In stock

Product specifications:​

  • Quality Standard clinical-grade
  • Product Concentration 10 mg/mL
  • Volume per vial 200 µL
  • Quantity per vial 2 mg
  • Origin of the commercial drug DE
  • Batch Number EC1216
  • Storage Temperature -80°C
  • Original therapeutic expiry date: 01/2025

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.
Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.
For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.
Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached. Further quality or functional testing are not performed on the drug aliquots.  

Class of molecule

Host cells

Murine hybridoma cells

Prepared from (Reference drug)​

Flixabi®

Therapeutic Area

Mechanism of Action (MoA)

Binds with high affinity to both soluble and transmembrane forms of TNF-α α but not to lymphotoxin α (TNFβ).

Pharmacotherapeutic group​​

Immunosuppressants, tumour necrosis factor alpha (TNFα) inhibitors

List of Excipients​

Sucrose
Polysorbate 80
Monobasic sodium phosphate monohydrate (for pH-adjustment)
Dibasic sodium phosphate heptahydrate (for pH-adjustment)

Batch specific analytical data available

Evidentic’s analytical service includes a comprehensive array of methods to support the drug development process, including, for example, structure, aggregation, degree of isomerization and N-glycans identification of the active pharmaceutical ingredient (API).

Infliximab

BATCH NUMBER: EC1216

Request an individual offer​

+ download a free sample​

1. Choose your(s) method(s) of interest
2. Provide your contact details
3. Send us your request and download a free sample report


Please provide your contact information


send us your inquiry and download a free sample file


More , , Reference Drugs as Aliquots

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD20
Biosimilar
,
Monoclonal Antibody
Ruxience®
10 mg/mL
2 mg
tba
tba
196,00 
view product
Max:
Min: 11
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Truxima®
10 mg/mL
2 mg
tba
tba
234,00 
view product
Max:
Min: 10
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Rixathon®
10 mg/mL
2 mg
-80 °C
03/2026
311,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Herzuma®
21 mg/mL
6 mg
tba
tba
356,00 
view product
Max:
Min: 7
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ontruzant®
21 mg/mL
2 mg
tba
tba
159,00 
view product
Max:
Min: 15
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Kanjinti®
21 mg/mL
6 mg
-80°C
01/2025
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Zercepac®
21 mg/mL
6 mg
-80°C
08/2026
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ogivri®
21 mg/mL
6 mg
-80°C
10/2025
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Trazimera®
21 mg/mL
2 mg
-80 °C
09/2026
159,00 
view product
Max: 10
Min: 2
Step: 1
1 2

Not looking for Infliximab EC1216?

Search our therapeutic molecules product database

Quick Ordering

Find and order your therapeutic molecules through smart filters

Multiple Batches

Up to 10 batches of original drugs for examining batch-to-batch variations

Reduce Costs

Up to 80% less compared to the original pharmaceutical price

Worldwide Shipping

Shipment within days worldwide according to GDP-standards

Precise Quantity​​

Up to 80% less compared to the original pharmaceutical price

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.